Literature DB >> 19320660

Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.

Juha W Koskenvuo1, Erik Engblom, Ilkka M Kantola, Jaakko J Hartiala, Antti Saraste, Tuomas O Kiviniemi, Ilkka Mononen, Markku Saraste.   

Abstract

BACKGROUND AND AIM: It has been reported that the endocardium in Fabry disease has a binary appearance on transthoracic echocardiography. It has been suggested that this sign could be used with good accuracy to differentiate Fabry disease from hypertrophic cardiomyopathy and even as a first filter to screen for suspected Fabry disease.
METHODS: Therefore, we performed a blinded echocardiography in a non-selected population of patients with Fabry disease and matched controls. We included 23 echocardiographic studies of Fabry patients.
RESULTS: Two of the Fabry patients had binary appearance of the endocardium. One of them had left ventricular hypertrophy (LVH) and the other had a normal left ventricular mass. Binary appearance of the endocardium was detected in four of the controls, and one of them had LVH. Subgroup analysis of patients who had LVH indicated a sensitivity of 12.5% and a specificity of 66.7% for binary appearance of the endocardium to detect Fabry disease as the underlying cause of LVH. Overall, binary appearance of the endocardium had a sensitivity and a specificity of 15.4 and 73.3%, respectively, to distinguish patients with Fabry disease from controls in our population.
CONCLUSIONS: Binary appearance of the endocardium is not feasible for screening Fabry disease by echocardiography.

Entities:  

Mesh:

Year:  2009        PMID: 19320660     DOI: 10.1111/j.1475-097X.2008.00851.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  5 in total

1.  Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).

Authors:  Hatim Y Ebrahim; Robert J Baker; Atul B Mehta; Derralynn A Hughes
Journal:  J Inherit Metab Dis       Date:  2011-10-05       Impact factor: 4.982

Review 2.  Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.

Authors:  R P Morrissey; K J Philip; E R Schwarz
Journal:  Cardiovasc J Afr       Date:  2011 Jan-Feb       Impact factor: 1.167

Review 3.  Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.

Authors:  Fábio Fernandes; Murillo Oliveira Antunes; Viviane Tiemi Hotta; Carlos Eduardo Rochitte; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

4.  The subaortic tendon as a mimic of hypertrophic cardiomyopathy.

Authors:  James Ker
Journal:  Cardiovasc Ultrasound       Date:  2009-07-03       Impact factor: 2.062

5.  Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Mariko Mikame; Atsushi Izawa; Naoki Morito; Kazufumi Izaki; Toshiyuki Seto; Akifumi Onishi; Hitoshi Sugiyama; Norio Sakai; Kenji Yamabe; Yukio Yokoyama; Satoshi Yamashita; Hiroshi Satoh; Shigeru Toyoda; Michihiro Hosojima; Yumi Ito; Ryushi Tazawa; Satoshi Ishii
Journal:  Curr Issues Mol Biol       Date:  2021-06-19       Impact factor: 2.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.